Trials / Recruiting
RecruitingNCT06571487
Growth Hormone Resistance of Beta-cells
Growth Hormone Resistance of Beta-cells in Women With Gestational Diabetes Mellitus
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a personal history of gestational diabetes (high blood sugar in pregnancy) at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing gestational diabetes and type 2 diabetes.
Conditions
Timeline
- Start date
- 2025-10-22
- Primary completion
- 2028-09-01
- Completion
- 2030-09-01
- First posted
- 2024-08-26
- Last updated
- 2025-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06571487. Inclusion in this directory is not an endorsement.